Display options
Cite
Sindura C, Babu C, Mysorekar V, et al. Study of immunohistochemical demonstration of Bcl-2 protein in ameloblastoma and keratocystic odontogenic tumor. J Oral Maxillofac Pathol. 2013;17(2):176-80doi: 10.4103/0973-029X.119750.
Sindura, C., Babu, C., Mysorekar, V., & Kumar, V. (2013). Study of immunohistochemical demonstration of Bcl-2 protein in ameloblastoma and keratocystic odontogenic tumor. Journal of oral and maxillofacial pathology : JOMFP, 17(2), 176-80. https://doi.org/10.4103/0973-029X.119750
Sindura, Cs, et al. "Study of immunohistochemical demonstration of Bcl-2 protein in ameloblastoma and keratocystic odontogenic tumor." Journal of oral and maxillofacial pathology : JOMFP vol. 17,2 (2013): 176-80. doi: https://doi.org/10.4103/0973-029X.119750
Sindura C, Babu C, Mysorekar V, Kumar V. Study of immunohistochemical demonstration of Bcl-2 protein in ameloblastoma and keratocystic odontogenic tumor. J Oral Maxillofac Pathol. 2013 May;17(2):176-80. doi: 10.4103/0973-029X.119750. PMID: 24250074; PMCID: PMC3830222.
Copy Download .nbib Format: NLM
Share it on

J Oral Maxillofac Pathol. 2013 May;17(2):176-80. doi: 10.4103/0973-029X.119750.

Study of immunohistochemical demonstration of Bcl-2 protein in ameloblastoma and keratocystic odontogenic tumor.

Journal of oral and maxillofacial pathology : JOMFP

Cs Sindura, Chaitanya Babu, Vijaya Mysorekar, Vinod Kumar

Affiliations

  1. Department of Oral Pathology, Srinivas Institute of Dental Science, Mangalore, Karnataka, India.

PMID: 24250074 PMCID: PMC3830222 DOI: 10.4103/0973-029X.119750

Abstract

BACKGROUND: The Bcl-2 (B-cell lymphoma) gene product also known as apoptotic inhibitor is expressed in many normal and tumor tissues. This Bcl-2 gene protects the cell by blocking postmitotic differentiation from apoptosis, thus maintaining the stem cell pool.

OBJECTIVE: To study the expression of Bcl-2 protein in ameloblastoma and keratocystic odontogenic tumor (KCOT) to determine their apoptotic behaviors and to analyze biological nature of KCOT, which has higher proliferative potential and aggressive clinical behavior like odontogenic tumors.

MATERIALS AND METHODS: Formalin-fixed paraffin sections of ameloblastoma (n = 20) and KCOT (n = 20) are considered for immunohistochemical analysis using monoclonal antibody against antihuman Bcl-2 oncoprotein. Lymphomas (n = 3) were used as controls.

STATISTICAL ANALYSIS: The statistical analysis was performed using software package of social science version 16. The data were analyzed using Chi-square test and Student's t test. In all the above tests, P < 0.05 was accepted as statistically significant.

RESULTS: The positive ratio of Bcl-2 was 85% (17/20) in ameloblastoma, 85% (17/20) in KCOT and 100% (3/3) in lymphomas. Bcl-2 was expressed in peripheral cells and few scattered cells of stellate reticulum in ameloblastoma. KCOT showed strong positivity for Bcl-2 mainly in the basal layer.

INTERPRETATION AND CONCLUSION: The present study demonstrates the aggressive nature of KCOT and intrinsic growth potential of its lining epithelium. This study clearly demonstrates that KCOT like ameloblastoma demonstrates aggressive clinical and noticeable invasive behavior. Therefore, it is now considered as no longer a developmental cyst but as odontogenic tumor.

Keywords: Ameloblastoma; B-cell lymphoma-2; keratocystic odontogenic tumor; lymphomas

References

  1. Oral Oncol. 1998 Sep;34(5):404-7 - PubMed
  2. J Can Dent Assoc. 2008 Mar;74(2):165-165h - PubMed
  3. Br Dent J. 1971 Sep 21;131(6):249-59 - PubMed
  4. Proc Finn Dent Soc. 1979;75(3):36-45 - PubMed
  5. J Oral Pathol Med. 1999 Sep;28(8):343-9 - PubMed
  6. Med Sci Monit. 2007 Mar;13(3):BR84-8 - PubMed
  7. Zhonghua Bing Li Xue Za Zhi. 1995 Apr;24(2):78-9 - PubMed
  8. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jun;85(6):692-8 - PubMed
  9. Histopathology. 2001 Jul;39(1):93-8 - PubMed

Publication Types